HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,077 | -99.9% | 18,928 | -18.1% | 0.03% | +8.0% |
| Q3 2022 | $914,000 | -12.6% | 23,122 | -2.8% | 0.02% | -7.4% |
| Q2 2022 | $1,046,000 | -1.1% | 23,776 | -10.4% | 0.03% | +12.5% |
| Q1 2022 | $1,058,000 | +19.1% | 26,526 | +20.2% | 0.02% | +26.3% |
| Q4 2021 | $888,000 | +7.5% | 22,076 | +8.7% | 0.02% | 0.0% |
| Q3 2021 | $826,000 | -10.2% | 20,316 | +0.2% | 0.02% | -13.6% |
| Q2 2021 | $920,000 | +8.7% | 20,270 | -0.1% | 0.02% | +4.8% |
| Q1 2021 | $846,000 | -0.8% | 20,300 | +1.7% | 0.02% | -4.5% |
| Q4 2020 | $853,000 | – | 19,970 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |